Aurinia Pharmaceuticals (AUPH) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Adjusted EPS
- $0.28
- Estimate
- $0.24
- Surprise
- +16.7%
- Revenue (period 2026-06-30)
- $83.2M
- Score today
- 6.9/10
Revenue source: xbrl.
How the report landed
Aurinia Pharmaceuticals (AUPH) beat the $0.24 estimate with adjusted EPS of $0.28 — a large 16.7% upside surprise.
Where TrendMatrix's rating stands now
TrendMatrix currently rates AUPH Buy (Wait) at 6.9/10; no pre/post engine snapshot brackets this report.
4 of the last 4 quarters beat the estimate; this quarter's +16.7% surprise compares with a +173.3% four-quarter average. Next scheduled report: 2026-11-09.
What supports the rating
- V7 flight-to-quality bonus: +0.5 (Q=8.8 in RISK_OFF)
- Sector modifier (Healthcare): +0.5
What argues against it
- Cyclical risk: PE expanding 2.1x (earnings normalizing)
- Analyst target reached - limited upside remaining
- Negative momentum
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $15.69
- Entry target
- $15.35
- Price target
- $16.82
- Stop
- $14.65
- Upside to target
- +7.2%
Forward estimates sit below the trailing run-rate (14.7× forward vs 6.9× trailing) — consensus expects earnings to decline from here.
Risk check: RSI 17 — a level conventionally read as oversold.
Model outputs from TrendMatrix’s engine as of 2026-10-07 — shown for context, not personalized investment advice.
AUPH at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Biotechnology
- Market cap
- $2.09B
- P/E (fwd)
- 14.7
- P/E (ttm)
- 6.9
- 52-week range
- $10.90–$19.25
- Off 52-week high
- 18.5%
- RSI (14)
- 17
- Volume vs avg
- 0.85×
- Score today
- 6.9/10